Translation Animal Models of Diabetic Kidney Disease: Biochemical and Histological Phenotypes, Advantages and Limitations
Wenting Luo,Shiyun Tang,Xiang Xiao,Simin Luo,Zixuan Yang,Wei Huang,Songqi Tang
DOI: https://doi.org/10.2147/DMSO.S408170
2023-05-05
Abstract:Wenting Luo, 1 Shiyun Tang, 2 Xiang Xiao, 1 Simin Luo, 1 Zixuan Yang, 1 Wei Huang, 3 Songqi Tang 1 1 School of Traditional Chinese Medicine, Hainan Medical University, Haikou, Hainan Province, People's Republic of China; 2 Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, People's Republic of China; 3 School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, People's Republic of China Correspondence: Wei Huang, School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, 611137, People's Republic of China, Email Songqi Tang, School of Traditional Chinese Medicine, Hainan Medical University, Haikou, Hainan Province, 571199, People's Republic of China, Tel +86 18689713500, Email Animal models play a crucial role in studying the pathogenesis of diseases, developing new drugs, identifying disease risk markers, and improving means of prevention and treatment. However, modeling diabetic kidney disease (DKD) has posed a challenge for scientists. Although numerous models have been successfully developed, none of them can encompass all the key characteristics of human DKD. It is essential to choose the appropriate model according to the research needs, as different models develop different phenotypes and have their limitations. This paper provides a comprehensive overview of biochemical and histological phenotypes, modeling mechanisms, advantages and limitations of DKD animal models, in order to update relevant model information and provide insights and references for generating or selecting the appropriate animal models to fit different experimental needs. Keywords: modeling, advanced diabetic kidney disease, diabetic complications, hypertension, atherosclerosis, non-proteinuric diabetic kidney disease Diabetic kidney disease (DKD) is a common microvascular complication of diabetes mellitus (DM) that is clinically characterized by a gradual decline in renal function, with or without proteinuria, due to prolonged hyperglycemia. There are no substantial differences between patients with type 1 DM (T1D) and those with type 2 DM (T2D) in the basic pathophysiological mechanisms leading to nephropathy. 1 The early glomerular pathologic changes in DKD are principally mesangial matrix expansion, glomerular basement membranes (GBM) thickening and compensatory glomerular hypertrophy causing ultrafiltration, which subsequently progresses to diffuse and/or nodular glomerulosclerosis with decreased glomerular filtration rate (GFR) and arterial hyalinosis. In addition, tubulointerstitial injury is a consistent feature of DKD, manifested by interstitial inflammation, tubular basement membrane thickening, tubular atrophy, and interstitial fibrosis. Chronic tubulointerstitial injury may be more severe than diabetic glomerulopathy in patients with T2D-DKD because of the more heterogeneous lesions often associated with atherosclerosis. 1 DKD can be found in 25–40% of diabetes and is one of the leading causes of end-stage renal disease (ESRD). 1 Additionally, its presence poses a significant cardiovascular risk and greatly increases cardiovascular mortality in patients. 2–4 As a prevalent chronic disease, DM already affects the health of more than 350 million people worldwide. Research has indicated that the number of diabetes is expected to reach 600 million by 2035, by which time more than one in ten adults will have DM, 5 suggesting that more people may suffer from DKD. Although a combination of glycemic control, anti-hypertension, lipid regulation, and lifestyle interventions has been clinically proven to be effective in slowing down the progression of DKD, 6 this disease remains incurable or irreversible. The etiology and pathogenesis of DKD are complex and not well understood, which is a major obstacle to developing clinical control methods. Suitable animal models can provide a basis for clinical treatment and important clues for studying the etiology, pathogenesis, and pathophysiological changes. 7 There are various animal models of DKD available; however, no single model can represent all the features of human DKD. Therefore, it is crucial to select a suitable animal model based on research needs and purposes. There are three classical categories of animal models of DKD used in laboratories: induced models (chemical, dietary, and surgical induction), spontaneous models and genetic models. DKD, especially T2D-DKD, is not clinically independent and is often accompanied by complications such as hyperlipidaemia, hypertension, and atherosclerosis. In addition, the increasing number of patients with non-protein -Abstract Truncated-
endocrinology & metabolism